Disclosures for "Prevalence and Characteristics of Itch in Patients with Parkinson’s Disease"
-
Mr. Mahmoud has nothing to disclose.
-
Dr. Marmol has nothing to disclose.
-
Dr. Feldman has nothing to disclose.
-
Dr. Yosipovitch has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer, Sanofi Regeneron, Galderma, Eli Lilly . Dr. Yosipovitch has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Regeneron, Pfizer, Galderma, Abbvie, GSK, Vifor . The institution of Dr. Yosipovitch has received research support from Regeneron Sanofi , Eli Lilly, Escient Novartis Abbvie .
-
The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation. The institution of Dr. Haq has received research support from NIMH. Dr. Haq has a non-compensated relationship as a consultant with Medtronics that is relevant to AAN interests or activities. Dr. Haq has a non-compensated relationship as a consultant with Boston Scientific that is relevant to AAN interests or activities. Dr. Haq has a non-compensated relationship as a consultant with Abbott that is relevant to AAN interests or activities.